Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-26

Clinical Trial Update: Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity? [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating a rescue course of betamethasone in pregnant women with preterm premature rupture of membranes (PPROM) to reduce neonatal morbidity…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • betamethasone (betamethasone)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: PPROM, Respiratory Distress Syndrome in Premature Infants | Phase 2, Phase 3 | Status: TERMINATED